Cost-effectiveness

Ophthalmology. 2008 Oct;115(10):1852-3; author reply 1853. doi: 10.1016/j.ophtha.2008.05.002.
No abstract available

Publication types

  • Comment
  • Letter

MeSH terms

  • Antihypertensive Agents / economics
  • Antihypertensive Agents / therapeutic use
  • Cost-Benefit Analysis
  • Decision Support Techniques
  • Glaucoma, Open-Angle / prevention & control
  • Health Care Costs
  • Health Services Research
  • Humans
  • Insurance, Health / statistics & numerical data
  • Intraocular Pressure
  • Markov Chains
  • National Health Programs / standards
  • Ocular Hypertension / economics*
  • Ocular Hypertension / therapy*
  • Quality of Life
  • Quality-Adjusted Life Years
  • Risk Factors
  • Trabeculectomy / economics
  • United States

Substances

  • Antihypertensive Agents